Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. Buxton, M., Alexander, B., Berry, D. A., Cavenee, W. K., Colman, H., De Groot, J., Ellingson, B. M., Gordon, G. B., Khasraw, M., Lassman, A. B., Li, W., Lim, M., Mellinghoff, I. K., Perry, J. R., Sulman, E. P., Tanner, K., Weller, M., Wen, P. Y., Yung, W., Cloughesy, T., GBM AGILE Investigators LIPPINCOTT WILLIAMS & WILKINS. 2020
View details for Web of Science ID 000560368309059